MyFinsight
Home
Blog
About
GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. (GOVX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,871,660
Free Cash flow
-$3,658,103
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from sale of common...
Net proceeds from warrant exerci...
Accounts payable and accrued exp...
Others
Negative Cash Flow Breakdown
Net loss
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-4,426,578
-5,261,921
-4,418,423
-6,318,914
Depreciation and amortization expense
12,076
12,076
18,230
16,802
Stock-based compensation expense
163,746
219,317
252,124
277,546
Government contract receivable
0
0
0
-532,771
Prepaid expenses and other current assets
-127,830
-1,072,281
674,826
-664
Other assets
-
-
-43,560
15,937
Accounts payable and accrued expenses
464,823
420,526
-182,441
-705,047
Total adjustments
768,475
1,724,200
-543,353
106,799
Net cash used in operating activities
-3,658,103
-3,537,721
-4,961,776
-6,212,115
Purchase of equipment
0
0
0
0
Net cash used in investing activities
0
0
0
0
Net proceeds from issuance of notes payable related parties
-
-
0
0
Repayment of notes payable related parties
-
-
0
0
Net proceeds from sale of common stock and warrants
3,554,080
1,718,901
3,038,520
7,971,250
Net proceeds from warrant exercises
1,975,683
4,841
0
156,000
Net cash provided by financing activities
5,529,763
1,723,742
3,038,520
8,127,250
Net increase (decrease) in cash and cash equivalents
1,871,660
-1,813,979
-1,923,256
1,915,135
Cash and cash equivalents at beginning of period
1,271,762
3,085,741
5,008,997
5,506,941
Cash and cash equivalents at end of period
3,143,422
1,271,762
3,085,741
5,008,997
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
sale of common stock...
$3,554,080
(-55.09%↓ Y/Y)
Net proceeds from
warrant exercises
$1,975,683
(945202.87%↑ Y/Y)
Net cash provided by
financing activities
$5,529,763
(-30.13%↓ Y/Y)
Accounts payable and
accrued expenses
$464,823
(180.40%↑ Y/Y)
Stock-based compensation
expense
$163,746
(-72.03%↓ Y/Y)
Prepaid expenses and
other current assets
-$127,830
(50.76%↑ Y/Y)
Depreciation and
amortization expense
$12,076
(-64.19%↓ Y/Y)
Net increase
(decrease) in cash and cash...
$1,871,660
(177.56%↑ Y/Y)
Canceled cashflow
$3,658,103
Total adjustments
$768,475
(79.82%↑ Y/Y)
Net cash used in
operating activities
-$3,658,103
(64.48%↑ Y/Y)
Canceled cashflow
$768,475
Net loss
-$4,426,578
(58.74%↑ Y/Y)
Buy us a coffee